0001104659-16-145191.txt : 20160916 0001104659-16-145191.hdr.sgml : 20160916 20160916170051 ACCESSION NUMBER: 0001104659-16-145191 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160914 FILED AS OF DATE: 20160916 DATE AS OF CHANGE: 20160916 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vitae Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001157602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043567753 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 502 WEST OFFICE CENTER DR CITY: FORT WASHINGTON STATE: PA ZIP: 19034 BUSINESS PHONE: 215-461-2000 MAIL ADDRESS: STREET 1: 502 WEST OFFICE CENTER DR CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Vitae Pharmaceuticals Inc DATE OF NAME CHANGE: 20050118 FORMER COMPANY: FORMER CONFORMED NAME: CONCURRENT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hatfield Jeffrey S. CENTRAL INDEX KEY: 0001609879 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36617 FILM NUMBER: 161889960 MAIL ADDRESS: STREET 1: 11080 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 a4.xml 4 X0306 4 2016-09-14 0 0001157602 Vitae Pharmaceuticals, Inc VTAE 0001609879 Hatfield Jeffrey S. C/O VITAE PHARMACEUTICALS, INC. 502 WEST OFFICE CENTER DR. FORT WASHINGTON PA 19034 1 1 0 0 Chief Executive Officer Common Stock 2016-09-14 4 S 0 50000 20.81 D 244996 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015. /s/ Jeffrey S. Hatfield 2016-09-16